☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Corgard discontinued

The manufacturer of nadolol (Corgard®) has confirmed that this product has been discontinued. The product has been discontinued for commercial reasons.

Nadolol, a beta blocker, is licensed for use in hypertension, angina, arrhythmias, migraine prophylaxis and adjunctive treatment of thyrotoxicosis. Supply chain stock will be limited and there is no generic alternative. Treatment should not be stopped abruptly and therefore patients who are currently being prescribed nadolol should be identified, reviewed offered an appropriate alternative.

Action: Clinicians should be aware of this product being discontinued. It would be prudent to run clinical system searches to identify any patients who are currently prescribed this product to allow a review and an alternative to be arranged.

Update: As of June 2018 it would seem that the manufacturer reversed the decision to discontinue Corgard® and the 80mg tablets remain available and in the supply chain.

Share 'Corgard discontinued' by emailShare 'Corgard discontinued' on FacebookShare 'Corgard discontinued' on TwitterShare 'Corgard discontinued' on LinkedInShare 'Corgard discontinued' on reddit


83 Comments to “Corgard discontinued”

  1. I have been taking Corgard and the generic form by Mylan for 40 years. Are they discontinuing this drug? Mylan is no longer producing it since they merged their company with a branch of Pfizer. I'm not sure what to do next. A beta blocker is the only thing that works! Calcium channel blockers do nothing! Are they making any form of Corgard? I take 80 mg tablets 2xs per day. Insurance only wants to pay for generics, and some of them don't work!

    Comment by Donna Blomberg — April 29, 2022 #

  2. I have been tasking Nadolol 80mg at 2 tablets in the am and 2 tablets in the pm. Today a 3 month supply cost was $200. I have been taking this drug for at least 40 yrs but the cost is way too much. Insurance is Humana Gold.

    Comment by Ardine Jones — April 26, 2022 #

Leave a Reply to Donna Blomberg Cancel reply

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.